Phosphodiesterase inhibitors /

Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of thes...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Schudt, Christian, Dent, Gordon, Rabe, Klaus F.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: San Diego : Academic Press, 1996.
Colección:Handbook of immunopharmacology. Drugs.
Temas:
Phosphodiesterases > Inhibitors.
Phosphodiesterases > Inhibitors > Therapeutic use.
Phosphodiesterase Inhibitors > therapeutic use
Phosphodiesterase Inhibitors > pharmacology
Phosphodiest�erases > Inhibiteurs.
Phosphodiest�erases > Inhibiteurs > Emploi en th�erapeutique.
MEDICAL > Biochemistry.
MEDICAL > Pharmacology.
Aufsatzsammlung
Immunpharmakologie
Inhibitor
Phosphodiesterasen
Acceso en línea:Texto completo
Tabla de Contenidos:
  • K.M. Ferguson and K. Loughney, Identification and Quantification of PDE Isoenzymes and Subtypes by Molecular Biological Methods.
  • H. Tenor and C. Schudt, Analysis of PDE Isoenzyme Profiles in Cells and Tissues by Pharmacological Methods.
  • K.F. Rabe, Effects of Theophylline and Nonselective Xanthine Derivatives on PDE Isoenzymes and Cellular Function.
  • R.K. Sharma, Interaction of PDE I Inhibitors with Isoenzymes and Cell Functions.
  • R. Fischmeister, EHNA as an Inhibitor of PDE II.
  • V.C. Manganiello, PDE II Inhibitors as Therapeutic Agents.
  • M.A. Giembycz, Interaction of PDE IV Inhibitors with Enzymes and Cell Functions and their Therapeutic Potential.
  • P.J. Silver, Inhibition of PDE Isoenzymes and Cell Function by Selective PDE V Inhibitors.
  • J.D. Corbin, Design and Synthesis of Xanthines and Cyclic GMP Analogues as Potent Inhibitors of PDE V and PDE I.
  • A. Hatzelmann, Enzymatic and Functional Inhibition of Dual-Selective Inhibitors.
  • R. Alvarez, Subtype Selectivity, Inhibition of Cell Function and Therapeutic Potential of RS 25344.
  • J.E. Souness, Characterization of Different States of PDE IV by Rolipram and RP 73401.
  • T.J. Torphy, Functional Significance of Two Sites for Inhibitors at PDE IV.
  • Subject Index.
  • Identification and quantification of PDE isoenzymes and subtypes by molecular biological methods
  • Analysis of PDE isoenzyme profiles in cells and tissues by pharmacological methods
  • Effects of theophylline and non-selective xanthine derivatives on PDE isoenzymes nad cellular function
  • Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase (PDEI)
  • EHNA as an inhibitor of PDE2; a pharmacological and biochemical study in cardiac myocytes
  • cGMP-inhibited phosphodiesterases (PDE3)
  • Interaction of PDE4 inhibitors with enzymes and cell functions
  • Inhibition of phosphodiesterase isoenzymes and cell function by selective PDE5 inhibitors
  • Design and synthesis of xanthines and cyclic GMP analogues as potent inhibitors of PDE5
  • Enzymatic and functional aspects of dual-selective PDE3/4 inhibitors
  • An isoform-selective inhibitor of cyclic AMP-specific phosphodiesterase (PDE4) with anti-inflammatory properties
  • Characterization of different states of PDE4 by rolipram and RP 73041
  • Molecular aspects of inhibitor interaction with PDE4.

Ejemplares similares